Integrated multimodal imaging of dynamic bone-tumor alterations associated with metastatic prostate cancer
Bone metastasis occurs for men with advanced prostate cancer which promotes osseous growth and destruction driven by alterations in osteoblast and osteoclast homeostasis. Patients can experience pain, spontaneous fractures and morbidity eroding overall quality of life. The complex and dynamic cellul...
Saved in:
Published in: | PloS one Vol. 10; no. 4; p. e0123877 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Public Library of Science
10-04-2015
Public Library of Science (PLoS) |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Bone metastasis occurs for men with advanced prostate cancer which promotes osseous growth and destruction driven by alterations in osteoblast and osteoclast homeostasis. Patients can experience pain, spontaneous fractures and morbidity eroding overall quality of life. The complex and dynamic cellular interactions within the bone microenvironment limit current treatment options thus prostate to bone metastases remains incurable. This study uses voxel-based analysis of diffusion-weighted MRI and CT scans to simultaneously evaluate temporal changes in normal bone homeostasis along with prostate bone metatastsis to deliver an improved understanding of the spatiotemporal local microenvironment. Dynamic tumor-stromal interactions were assessed during treatment in mouse models along with a pilot prospective clinical trial with metastatic hormone sensitive and castration resistant prostate cancer patients with bone metastases. Longitudinal changes in tumor and bone imaging metrics during delivery of therapy were quantified. Studies revealed that voxel-based parametric response maps (PRM) of DW-MRI and CT scans could be used to quantify and spatially visualize dynamic changes during prostate tumor growth and in response to treatment thereby distinguishing patients with stable disease from those with progressive disease (p<0.05). These studies suggest that PRM imaging biomarkers are useful for detection of the impact of prostate tumor-stromal responses to therapies thus demonstrating the potential of multi-modal PRM image-based biomarkers as a novel means for assessing dynamic alterations associated with metastatic prostate cancer. These results establish an integrated and clinically translatable approach which can be readily implemented for improving the clinical management of patients with metastatic bone disease. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 Competing Interests: BDR, AR, TLC and CJG have a financial interest in the underlying technology which has been licensed to Imbio, LLC a company in which BDR and AR have a financial interest. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. Conceived and designed the experiments: BDR MH TLC JAJ AR TDJ KJP CJG. Performed the experiments: JCB BAH TLC JAJ SG TS ASA. Analyzed the data: JCB BAH TLC JLB TDJ KJP CJG CRM TS ASA MH BDR. Contributed reagents/materials/analysis tools: BAH TLC JAJ JLB SG AR TDJ KJP CJG CRM KN ASA MH BDR. Wrote the paper: JCB BAH TLC JAJ AR TDJ KJP CJG CRM TS KN ASA MH BDR. MH and BDR are co-senior authors on this work. |
ISSN: | 1932-6203 1932-6203 |
DOI: | 10.1371/journal.pone.0123877 |